ATE430729T1 - Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptoren - Google Patents
Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptorenInfo
- Publication number
- ATE430729T1 ATE430729T1 AT04809674T AT04809674T ATE430729T1 AT E430729 T1 ATE430729 T1 AT E430729T1 AT 04809674 T AT04809674 T AT 04809674T AT 04809674 T AT04809674 T AT 04809674T AT E430729 T1 ATE430729 T1 AT E430729T1
- Authority
- AT
- Austria
- Prior art keywords
- glutama
- potentiators
- pyrrole
- receptors
- pyrazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03380224 | 2003-10-08 | ||
US53779404P | 2004-01-20 | 2004-01-20 | |
PCT/US2004/028815 WO2005040110A1 (en) | 2003-10-08 | 2004-09-27 | Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE430729T1 true ATE430729T1 (de) | 2009-05-15 |
Family
ID=34524773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04809674T ATE430729T1 (de) | 2003-10-08 | 2004-09-27 | Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptoren |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1670757B1 (de) |
AR (1) | AR049417A1 (de) |
AT (1) | ATE430729T1 (de) |
CA (1) | CA2541458C (de) |
DE (1) | DE602004021011D1 (de) |
ES (1) | ES2324044T3 (de) |
PE (1) | PE20050476A1 (de) |
TW (1) | TW200526574A (de) |
WO (1) | WO2005040110A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0608642A2 (pt) * | 2005-03-16 | 2010-01-19 | Aventis Pharma Inc | dipirazàis como agentes do sistema nervoso central |
TW201431849A (zh) * | 2005-06-06 | 2014-08-16 | Lilly Co Eli | Ampa受體強化劑 |
TW200817385A (en) * | 2006-07-04 | 2008-04-16 | Organon Nv | Heterocyclic derivatives |
DE102007007605A1 (de) | 2007-02-13 | 2008-08-14 | J. Eberspächer GmbH & Co. KG | Brennstoffzellensystem |
JP2010143826A (ja) * | 2007-04-12 | 2010-07-01 | Mitsui Chemicals Inc | 3−アミノチオフェン誘導体の製造方法 |
TW200922586A (en) * | 2007-10-26 | 2009-06-01 | Astrazeneca Ab | Thiophene 1,2,4-triazole derivatives as modulators of mGluR5 |
WO2009054789A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
WO2009054792A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Aminopyridine derivatives as modulators of mglur5 |
WO2009054791A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
TW200934497A (en) | 2007-11-13 | 2009-08-16 | Organon Nv | Heterocyclic derivatives |
TW201012803A (en) | 2008-06-06 | 2010-04-01 | Organon Nv | Heterocyclic derivatives |
WO2010009029A2 (en) * | 2008-07-15 | 2010-01-21 | Wyeth | Methods for the preparation of azole compounds |
KR101724293B1 (ko) | 2009-02-25 | 2017-04-07 | 다케다 야쿠힌 고교 가부시키가이샤 | 피롤 화합물의 제조 방법 |
US8633237B2 (en) | 2009-04-09 | 2014-01-21 | Merck Sharp & Dohme B.V. | Indane derivatives |
CA2773119C (en) | 2009-09-29 | 2015-04-14 | Albemarle Corporation | Processes for producing 3-(methylthio) thiophene |
WO2012020820A1 (ja) * | 2010-08-11 | 2012-02-16 | 大正製薬株式会社 | ヘテロアリール-ピラゾール誘導体 |
WO2012065947A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | 5-halogenopyrazolecarboxamides |
JP2014062047A (ja) * | 2011-01-21 | 2014-04-10 | Taisho Pharmaceutical Co Ltd | ピラゾール誘導体 |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
SI2953942T1 (en) | 2013-02-06 | 2018-03-30 | Bayer Cropscience Ag | Halogen-substituted pyrazole derivatives such as pesticides |
AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
CN105102448B (zh) | 2013-02-28 | 2018-03-06 | 百时美施贵宝公司 | 作为rock1和rock2抑制剂的苯基吡唑衍生物 |
TWI688557B (zh) | 2013-11-27 | 2020-03-21 | 德商拜耳動物保健有限公司 | 用於製備5-氟-1h-吡唑之方法(一) |
US9845312B2 (en) * | 2013-11-27 | 2017-12-19 | Bayer Cropscience Aktiengesellschaft | Process for the preparation of 5-fluoro-1H-pyrazoles |
US10273226B2 (en) | 2014-01-03 | 2019-04-30 | Bayer Animal Health Gmbh | Pyrazolyl-heteroarylamides as pesticides |
KR102540220B1 (ko) | 2014-08-19 | 2023-06-02 | 바이엘 애니멀 헬스 게엠베하 | 헥사플루오로프로펜으로부터 5-플루오로-1h-피라졸의 제조 방법 |
EP3268353B1 (de) | 2015-03-10 | 2020-09-09 | Bayer Animal Health GmbH | Pyrazolyl-derivate als schädlingsbekämpfungsmittel |
WO2017169894A1 (ja) | 2016-03-31 | 2017-10-05 | 住友化学株式会社 | 複素環化合物 |
WO2017175613A1 (ja) | 2016-04-06 | 2017-10-12 | 住友化学株式会社 | 複素環化合物 |
CN111393348B (zh) * | 2020-04-24 | 2023-03-28 | 黑龙江大学 | 一种氮位取代苯基吡咯类化合物及其在植物杀菌中的用途 |
CN113831280B (zh) * | 2021-11-01 | 2023-08-15 | 上海埃农生物科技有限公司 | 一种啶酰菌胺的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776954A (en) * | 1996-10-30 | 1998-07-07 | Merck & Co., Inc. | Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
PE20000942A1 (es) * | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
-
2004
- 2004-09-27 EP EP04809674A patent/EP1670757B1/de not_active Not-in-force
- 2004-09-27 AT AT04809674T patent/ATE430729T1/de not_active IP Right Cessation
- 2004-09-27 DE DE602004021011T patent/DE602004021011D1/de active Active
- 2004-09-27 WO PCT/US2004/028815 patent/WO2005040110A1/en active Application Filing
- 2004-09-27 CA CA2541458A patent/CA2541458C/en not_active Expired - Fee Related
- 2004-09-27 ES ES04809674T patent/ES2324044T3/es active Active
- 2004-10-06 PE PE2004000971A patent/PE20050476A1/es not_active Application Discontinuation
- 2004-10-07 TW TW093130424A patent/TW200526574A/zh unknown
- 2004-10-07 AR ARP040103638A patent/AR049417A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW200526574A (en) | 2005-08-16 |
PE20050476A1 (es) | 2005-08-24 |
ES2324044T3 (es) | 2009-07-29 |
CA2541458A1 (en) | 2005-05-06 |
EP1670757A1 (de) | 2006-06-21 |
DE602004021011D1 (de) | 2009-06-18 |
EP1670757B1 (de) | 2009-05-06 |
AR049417A1 (es) | 2006-08-02 |
CA2541458C (en) | 2011-09-20 |
WO2005040110A1 (en) | 2005-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE430729T1 (de) | Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptoren | |
DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
ATE461191T1 (de) | N-substituierte 2-oxodihydropyridinderivate als npy antagonisten | |
ATE365719T1 (de) | O-cyclopropyl-carboxanilide und ihre verwendung als fungizide | |
DE60234167D1 (de) | Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren | |
DE60320529D1 (de) | Chinolinderivate als npy antagonisten | |
ATE323072T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
DE602004015724D1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
ATE399768T1 (de) | Indazolderivate und ihre verwendung als crf antagonisten | |
DE602004024420D1 (de) | Chinazolinderivate als antitumormittel | |
DE60021423D1 (de) | 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren | |
MA28703B1 (fr) | Dérivés d'hétéroaryle et phénylsulfamoyle substitués | |
ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
ATE398107T1 (de) | N-pyrrolidin-3-yl-amide-derivate als inhibitoren der serotonin- und noradrenalin-wiederaufnahme | |
ATE393159T1 (de) | Heterobicyclische pyrazolderivate als kinaseinhibitoren | |
ATE438395T1 (de) | Pyrazolderivate und ihre verwendung als orexin- rezeptor-antagonisten | |
ATE292115T1 (de) | Indolderivate als cox-ii-inhibitoren | |
DE50313157D1 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
ATE427748T1 (de) | Pyridin-derivate und ihre verwendung als urotensin ii antagonisten | |
DE60318317D1 (de) | Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren | |
DE60302152D1 (de) | Diaminothiazole und ihre anwendung als cdk4 inhibitoren | |
DE50209680D1 (de) | Pyrazolylsubstituierte heterocyclen und ihre verwendung als schädlingsbekämpfungsmittel | |
DE602004006627D1 (de) | Nicotinamid-derivate verwendbar als pde4 inhibitoren | |
ATE394372T1 (de) | G-lactamderivate als prostaglandinagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |